Support NETRF to Foster Innovation and Fuel Discovery
This year our progress signals both the hope and promise of our efforts for you, your family and the patients we serve: together we are getting closer to improved treatments and ultimately cures. As we continue on in the fight against NETs, we are counting on your support for our work.
Patient Resources
Thank you for your Generous Donation!
Your support enables the NET Research Foundation to make rapid progress toward discovering cures for carcinoid, pancreatic, and related neuroendocrine cancers. Tribute gifts can be made in honor or memory of a loved one.
NETRF Recognized as Top-Tier Charity
NETRF’s strong financial position, transparency, and accountability again earned it a 4-star rating by Charity Navigator, a national evaluator of nonprofits. The 4-star rating indicates the utmost in fiscal responsibility, ethical practices, and governance.
News & Updates
Record Setting Number of Requests for Funding
July 11, 20182018 grant recipients. On May 16, 2018, NETRF released its annual Request for Applications (RFA) and invited investigators and teams of investigators from around the world to submit Letters of Intent (LOIs) describing novel and transformative
The Road to PRRT: A Path of Self-Discovery and Growth
July 10, 2018By Josie Rubio, NET Blogger, A Pain in the Neck Sitting on a yoga mat in a Brooklyn park, looking across at the Manhattan skyline, I recently found myself taking stock of how much had changed
NETRF Works to Take PRRT to Next Level
July 10, 2018The Neuroendocrine Tumor Research Foundation (NETRF) has invested more than $1.5 million in advancing a precision form of radiation therapy for NETs called Peptide Receptor Radionuclide Therapy (PRRT). Improving efficacy and safety Three NETRF-funded studies are
